目的:筛查肥厚型心肌病(HCM)致病基因突变位点并解析该突变的特点和临床症状,以期为HCM的基因诊断和治疗提供理论支持。方法:采集患者家系的血液样本并收集其临床资料,对先证者采取全外显子组测序方法,利用Sanger测序法对先证者的致病突变位点在家系及307名正常对照组人群中验证,结合文献报道,通过同源性比对和多种生物信息学方法分析该突变的致病性。结果:全外显子组测序发现先证者携带β肌球蛋白重链基因(MYH7) c.G428A突变,该家庭中3人携带该突变,2人被诊断为HCM,表现出HCM特征性临床表现,其他家人及对照组人群均未发现上述突变。不同物种同源性比对提示该位点的所编码的第146位氨基酸具有高度保守性,不同生物信息学方法分析该突变位点是有害突变。结论:MYH7基因c.G428A是有害突变,发病患者可能会表现出严重临床表现,具有致病性。
Objective: To screen the pathogenic gene mutation of hypertrophic cardiomyopathy (HCM) and an-alyze the characteristics and clinical symptoms of the mutation, in order to provide theoretical support for the genetic diagnosis and treatment of HCM. Methods: Blood samples from the patient’s family were collected and their clinical data were collected. Whole exome sequencing was used for the proband, and Sanger sequencing was used to verify the proband’s pathogenic mutation in the family and 307 normal control populations, combined with literature reports, the pathogenicity of the mutation was analyzed by homology alignment and various bioinformatics methods. Results: Whole exome sequencing revealed that in the proband carried the c.G428A mutation in the β-myosin heavy chain gene (MYH7), 3 members of the family carried the mutation, and 2 were di-agnosed with HCM, showing the characteristic clinical manifestations of HCM. The above mutations were not found in other family members and the control group. The homology alignment of differ-ent species indicated that the 146th amino acid encoded by this site is highly conserved, and dif-ferent bioinformatics methods analyzed the mutation site as a deleterious mutation. Conclusion: MYH7 gene c.G428A is a deleterious mutation that is pathogenic in patients with severe clinical manifestations.
肥厚型心肌病,β肌球蛋白重链基因,Arg143Gln,基因突变, Hypertrophic Cardiomyopathy β-Myosin Heavy Chain Gene Arg143Gln Gene Mutation摘要
1School of Basic Medical, Qingdao University, Qingdao Shandong
2Department of Pathology, Qingdao University Affiliated Hospital, Qingdao Shandong
Received: May 10th, 2022; accepted: May 27th, 2022; published: Jun. 13th, 2022
ABSTRACT
Objective: To screen the pathogenic gene mutation of hypertrophic cardiomyopathy (HCM) and analyze the characteristics and clinical symptoms of the mutation, in order to provide theoretical support for the genetic diagnosis and treatment of HCM. Methods: Blood samples from the patient’s family were collected and their clinical data were collected. Whole exome sequencing was used for the proband, and Sanger sequencing was used to verify the proband’s pathogenic mutation in the family and 307 normal control populations, combined with literature reports, the pathogenicity of the mutation was analyzed by homology alignment and various bioinformatics methods. Results: Whole exome sequencing revealed that in the proband carried the c.G428A mutation in the β-myosin heavy chain gene (MYH7), 3 members of the family carried the mutation, and 2 were diagnosed with HCM, showing the characteristic clinical manifestations of HCM. The above mutations were not found in other family members and the control group. The homology alignment of different species indicated that the 146th amino acid encoded by this site is highly conserved, and different bioinformatics methods analyzed the mutation site as a deleterious mutation. Conclusion: MYH7 gene c.G428A is a deleterious mutation that is pathogenic in patients with severe clinical manifestations.
Keywords:Hypertrophic Cardiomyopathy, β-Myosin Heavy Chain Gene, Arg143Gln, Gene Mutation
吕家磊,单正宜,刘荟婷,焦俊杰,信芳杰,赵 鹏. 肥厚型心肌病MYH7基因Arg143Gln的突变分析Mutation Analysis of MYH7 Gene Arg143Gln in Hypertrophic Cardiomyopathy[J]. 临床医学进展, 2022, 12(06): 5189-5196. https://doi.org/10.12677/ACM.2022.126752
参考文献ReferencesMaron, B., Rowin, E. and Maron, M. (2018) Global Burden of Hypertrophic Cardiomyopathy. JACC: Heart Failure, 6, 376-378. <br>https://doi.org/10.1016/j.jchf.2018.03.004Du, Y., Wang, Y., Han, X., Feng, Z. and Ma, A. (2019) MYH7 Gene-Related Mutation P.V878l Identified in a Chinese Family with Hypertrophic Cardiomyopathy. Internation-al Heart Journal, 60, 1415-1420.
<br>https://doi.org/10.1536/ihj.19-146Coats, C. and Elliott, P. (2013) Genetic Biomarkers in Hypertrophic Car-diomyopathy. Biomarkers in Medicine, 7, 505-516. <br>https://doi.org/10.2217/bmm.13.79Arimura, T., Hayashi, T. and Kimura, A. (2007) Molecular Etiology of Idiopathic Cardiomyopathy. Acta Myologica, 26, 153-158.Wang, H., Lin, Y., Zhang, R., Chen, Y., Ji, W., Li, S., et al. (2022) Viaprogrammed Exercise Attenuates Familial Hypertrophic Cardiomyopathy in Transgenic E22k Mice Inhibition of Pkc-Α/Nfat Pathway. Frontiers in Cardiovascular Medicine, 9, Article ID: 808163. <br>https://doi.org/10.3389/fcvm.2022.808163Teare, D. (1958) Asymmetrical Hypertrophy of the Heart in Young Adults. Heart, 20, 1-8.
<br>https://doi.org/10.1136/hrt.20.1.1Maron, B., Maron, M. and Semsarian, C. (2012) Genetics of Hypertrophic Cardiomyopathy after 20 Years: Clinical Perspectives. Journal of the American College of Cardiology, 60, 705-715. <br>https://doi.org/10.1016/j.jacc.2012.02.068Maron, B. and Maron, M. (2016) The Remarkable 50 Years of Imaging in HCM and How It Has Changed Diagnosis and Management: From M-Mode Echocardiography to CMR. JACC: Cardiovascular Imaging, 9, 858-872.
<br>https://doi.org/10.1016/j.jcmg.2016.05.003Ackerman, M., Priori, S., Willems, S., Berul, C., Brugada, R., Calkins, H., et al. (2011) HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopa-thies and Cardiomyopathies This Document Was Developed as a Partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). EP Europace, 8, 1077-1109. <br>https://doi.org/10.1093/europace/eur245Wang, B., Wang, J., Wang, L., Yang, F., Xu, L., Li, W.X., et al. (2019) Genetic Analysis of Monoallelic Double MYH7 Mutations Responsible for Familial Hypertrophic Cardiomyopa-thy. Molecular Medicine Reports, 20, 5229-5238.
<br>https://doi.org/10.3892/mmr.2019.10754吴桂鑫, 邹玉宝, 康连鸣, 惠汝太, 宋雷, 许连军. 《2020年AHA/ACC肥厚型心肌病诊断及治疗指南》解读[J]. 中国分子心脏病学杂志, 2020, 20(6): 3594-3597.Geske, J., Ommen, S. and Gersh, B. (2018) Hypertrophic Cardiomyopathy: Clinical Update. JACC: Heart Failure, 6, 364-375. <br>https://doi.org/10.1016/j.jchf.2018.02.010The 1000 Genomes Project Consortium (2015) A Global Reference for Human Genetic Variation. Nature, 526, 68-74.
<br>https://doi.org/10.1038/nature15393Lek, M., Karczewski, K., Minikel, E., Samocha, K.E., Banks, E., Fennell, T., et al. (2016) Analysis of Protein-Coding Genetic Variation in 60,706 Humans. Nature, 536, 285-291. <br>https://doi.org/10.1038/nature19057Homburger, J., Green, E., Caleshu, C., Sunitha, M.S., Taylor, R.E., Ruppel, K.M., et al. (2016) Multidimensional Structure-Function Relationships in Human β-Cardiac Myosin from Popu-lation-Scale Genetic Variation. Proceedings of the National Academy of Sciences of the United States of America, 113, 6701-6706.
<br>https://doi.org/10.1073/pnas.1606950113Lee, S., Ashley, E., Homburger, J., Caleshu, C., Green, E.M., Jacoby, D., et al. (2018) Incident Atrial Fibrillation Is Associated with MYH7 Sarcomeric Gene Variation in Hyper-trophic Cardiomyopathy. Circulation: Heart Failure, 11, Article ID: e005191. <br>https://doi.org/10.1161/CIRCHEARTFAILURE.118.005191Mattivi, C., Bos, J., Bagnall, R., Nowak, N., Giudicessi, J.R., Ommen, S.R., et al. (2020) Clinical Utility of a Phenotype-Enhanced MYH7-Specific Variant Classifi-cation Framework in Hypertrophic Cardiomyopathy Genetic Testing. Circulation: Genomic and Precision Medicine, 13, 453-459. <br>https://doi.org/10.1161/CIRCGEN.120.003039Marian, A. and Braunwald, E. (2017) Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circulation Research, 121, 749-770. <br>https://doi.org/10.1161/CIRCRESAHA.117.311059Marian, A. (2021) Molecular Genetic Basis of Hypertrophic Cardiomyopathy. Circulation Research, 128, 1533-1553.
<br>https://doi.org/10.1161/CIRCRESAHA.121.318346Kimura, A., Ito-Satoh, M., Hayashi, T., Takahashi, M. and Arimura, T. (2001) Molecular Etiology of Idiopathic Cardiomyopathy in Asian Populations. Journal of Cardiology, 37, 139-146.Kimura, A. (2010) Molecular Basis of Hereditary Cardiomyopathy: Abnormalities in Calcium Sensi-tivity, Stretch Response, Stress Response and beyond. Journal of Human Genetics, 55, 81-90. <br>https://doi.org/10.1038/jhg.2009.138钟海雷, 李妍伸, 杜彬彬, 邢清和, 贺林, 张彦周. 中国一肥厚型梗阻性心肌病家系MYH7基因Arg143Gln突变研究[J]. 中国优生优育, 2014, 20(3): 137-140.邵春丽. 肥厚型心肌病的梗阻机制及基因型——表型的关联研究[D]: [博士学位论文]. 北京: 清华大学医学部, 2010.Sedaghat-Hamedani, F., Kayvanpour, E., Tugrul, O., Lai, A., Amr, A., Haas, J., et al. (2018) Clinical Out-comes Associated with Sarcomere Mutations in Hypertrophic Cardiomyopathy: A Meta-Analysis on 7675 Individuals. Clinical Research in Cardiology, 107, 30-41. <br>https://doi.org/10.1007/s00392-017-1155-5Viswanathan, S., Sanders, H., Mcnamara, J., Jagadeesan, A., Jahangir, A., Tajik, A.J., et al. (2017) Hypertrophic Cardiomyopathy Clinical Phenotype Is Independent of Gene Mutation and Mutation Dosage. PLOS ONE, 12, Article ID: e0187948. <br>https://doi.org/10.1371/journal.pone.0187948